Global Immunoprotein Diagnostic Testing (Radioimmunoassay, Enzyme Based, Chemiluminescence Assay, Immunofluorescence Assay, Immunoturbidity Assayand Immunoprotein Electrophoresis) Market - Forecast to 2019 - AZTV7/Cable 13, Me-TV 7.2, HSN 7.3, Phoenix-Prescott, AZ

Global Immunoprotein Diagnostic Testing (Radioimmunoassay, Enzyme Based, Chemiluminescence Assay, Immunofluorescence Assay, Immunoturbidity Assayand Immunoprotein Electrophoresis) Market - Forecast to 2019

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, May 9, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/3qbnrh/immunoprotein) has announced the addition of the "Immunoprotein Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Immunoproteins being a part of body's defense mechanism, show characteristic serum concentration under abnormal conditions. Concentration of these proteins has been a prominent indicator for diagnosis of diseased state. On exposure to antigen, their levels increase 10 to 100 fold within 24 to 48 hours. These immunoproteins are thus a potential indicator for disease diagnosis. Application of these immunoproteins have shifted paradigm from microbial testing to rapid testing.

Chemiluminescence assay market was identified as the fastest growing segment owing to ease of use, sensitivity, and wide scope of application. The ELISA market will be fueled by introduction of multiplex ELISA technologies. On the other hand, the radioimmunoassay marketis expected to decline as it is being replaced by better and safer technologies such as ELISA, chemiluminescence assay, immunofluorescence assay and others.

Government restriction on the use of radioactive substances have drastically affected the market growth. Compliance with regulatory agencies, high cost of assay equipment and safety devices have further restrained the growth of radioimmunoassay market. Immunofluorescence and immunoturbidity assay segments will be growing at a moderate CAGR of about 5% during the forecast period.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Global Immunoprotein Diagnostic Testing Market Overview

Chapter 4 Global Immunoprotein Diagnostic Testing Market, by Assay Technology

Chapter 5 Global Immunoprotein Diagnostic Testing Market, by Immunoprotein Type

Chapter 6 Global Immunoprotein Diagnostic Testing Market, by Application

Chapter 7 Global Immunoprotein Diagnostic Testing Market, by Geography

Chapter 8 Recommendations

Chapter 9 Company Profiles

Companies Mentioned:

  • Abbott Laboratories, Inc.
  • Abcam PLC
  • DiaSorin SPA
  • Enzo Life Sciences, Inc.
  • Fujirebio Diagnostics, Inc.
  • Omega Diagnostics Group PLC
  • Randox Laboratories Ltd.
  • Roche Holding AG
  • Siemens AG
  • The Binding Site Group Ltd.
  • Thermo Fisher Scientific, Inc.

For more information visit http://www.researchandmarkets.com/research/3qbnrh/immunoprotein

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and AZ-TV. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.